中国组织工程研究

中国组织工程研究 ›› 2011, Vol. 15 ›› Issue (3): 487-490.doi: 10.3969/j.issn.1673-8225.2011.03.026

• 生物材料临床实践 clinical practice of biomaterials • 上一篇    下一篇

国产可降解雷帕霉素药物洗脱支架置入的疗效评价：与金属裸支架比较

赵红丽，李  潞，王  帅，李  纯   

  1. 沈阳医学院沈洲医院心内科，辽宁省沈阳市   110002
  • 收稿日期:2010-07-21 修回日期:2010-09-26 出版日期:2011-01-15 发布日期:2011-01-15
  • 通讯作者: 李潞，主任医师，博士，沈阳医学院沈洲医院心内科，辽宁省沈阳市 110002
  • 作者简介:赵红丽★，女，1972年生，辽宁省沈阳市人，汉族， 1996年中国医科大学毕业，硕士，副主任医师，主要从事冠心病病因学研究。 zhao_hongli@sina.com.cn
  • 基金资助:

    沈阳科学技术计划项目（1081284-9-00）。

Efficacy of homemade biodegradable rapamycin drug-eluting stent implantation: Compared with bare-metal stents

Zhao Hong-li, Li Lu, Wang Shuai, Li Chun   

  1. Department of Cardiology, Shenzhou Hospital Affiliated to Shenyang Medical College, Shenyang   110002, Liaoning Province, China
  • Received:2010-07-21 Revised:2010-09-26 Online:2011-01-15 Published:2011-01-15
  • Contact: Li Lu, Doctor, Chief physician, Department of Cardiology, Shenzhou Hospital Affiliated to Shenyang Medical College, Shenyang 110002, Liaoning Province, China liluxin5@yahoo.com.cn
  • About author:Zhao Hong-li★, Master, Associate chief physician, Department of Cardiology, Shenzhou Hospital Affiliated to Shenyang Medical College, Shenyang 110002, Liaoning Province, China zhao_hongli@sina.com.cn
  • Supported by:

    Science and Technology Program of Shenyang, No. 1081284-9-00*

PDF

368

摘要：

背景：药物洗脱支架明显降低了再狭窄率，但永久聚合物涂层在抑制血管平滑肌细胞增生的同时，阻碍血管完全内皮化进程，促使再狭窄发生，且永久聚合物涂层可引发晚期血栓等并发症。
目的：观察冠心病合并糖尿患者置入国产可降解药物洗脱支架后的远期疗效和安全性，并与置入金属裸支架患者进行比较。
方法：实验组选择冠心病合并2型糖尿病患者136例，首次经皮冠状动脉成形治疗，置入国产可降解药物洗脱支架(EXCELTM)，并以同期行金属裸支架置入治疗的冠心病合并2型糖尿病患者87例为对照组，随访12个月以上，记录主要不良心血管事件发生情况，并复查冠状动脉造影。
结果与结论：实验组129例，对照组83例完成(13.5±3.5)个月随访，实验组及对照组分别有8例及12例患者发生不良心血管事件，两组间差异有显著性意义(P=0.045)，对照组靶血管血运重建及再发心绞痛多于实验组(P < 0.05)。两组患者随访冠状动脉造影的定量分析提示实验组最终丢失指数小于对照组(P < 0.05)，再狭窄率低于对照组(P < 0.05)。说明对于冠心病合并糖尿病患者，应用国产可降解药物洗脱支架可降低不良心血管事件发生率，减少再狭窄，改善患者远期预后，安全性能良好。

关键词: 血管成形, 裸支架, 可降解药物洗脱支架, 经皮冠状动脉, 糖尿病

Abstract:

BACKGROUND: The drug-eluting stent (DES) can obviously decrease restenosis rate, but permanent polymer coating impedes the process of vascular endothelial and promotes restenosis, cause many complications such as late thrombosis at the same time of the inhibition of vascular smooth muscle cells proliferation.
OBJECTIVE: To investigate the long-term outcomes and safety after homemade biodegradable DES implantation for patients with coronary artery disease and diabetes mellitus, and compare with bare-metal stents.
METHODS: A total of 136 consecutive patients of coronary artery disease and type-2 diabetes mellitus, receiving homemade biodegradable DES (EXCELTM) implantation following percutaneous coronary angioplasty were studied as DES group; A total of 87 patients with coronary artery disease and type-2 diabetes mellitus treated with bare-metal stents were included as control group. All patients were identified and followed up at least 12 months. The differences of major adverse cardiovascular events were recorded and the patients were rechecked undergoing quantitative coronary angiography.
RESULTS AND CONCLUSION: A total 129 patients in DES group and 83 patients in control group accomplished follow-up at a mean time of (13.5±3.5) months. There were 8 patients and 12 patients in DES group and control group appeared major adverse cardiovascular events with significant difference between the two groups (P=0.045), the rate of target vessel revascularization and repeated angina were higher control group than in BMS group (P < 0.05). The late loss index and restenosis rate with DES were lower when underwent quantitative coronary angiograph follow-up (P < 0.05). The restenosis and major adverse cardiovascular events were reduced by homemade biodegradable DES in coronary heart disease patients with diabetic mellitus, and DES is safe and effective with improved long-termed prognosis.

中图分类号: